Does TOFACITINIB Cause Haemorrhage? 574 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 574 reports of Haemorrhage have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.4% of all adverse event reports for TOFACITINIB.
574
Reports of Haemorrhage with TOFACITINIB
0.4%
of all TOFACITINIB reports
10
Deaths
142
Hospitalizations
How Dangerous Is Haemorrhage From TOFACITINIB?
Of the 574 reports, 10 (1.7%) resulted in death, 142 (24.7%) required hospitalization, and 22 (3.8%) were considered life-threatening.
Is Haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 574 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Haemorrhage?
RIVAROXABAN (6,571)
APIXABAN (4,770)
EMICIZUMAB-KXWH (3,612)
WARFARIN (2,930)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (2,925)
ASPIRIN (2,878)
ADALIMUMAB (2,681)
IBRUTINIB (1,907)
CLOPIDOGREL BISULFATE (1,762)
INSULIN LISPRO (1,614)
Which TOFACITINIB Alternatives Have Lower Haemorrhage Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN